Bayer

Bayer is a multinational pharmaceutical company specializing in medicines, crop science, and health solutions. The company has embraced artificial intelligence as a strategic tool for drug discovery, partnering with Iambic to utilize advanced AI platforms in its research pipeline. This adoption reflects how traditional pharmaceutical development is integrating computational methods to accelerate innovation.

Bayer maintains a robust international research ecosystem. In June 2026, the company extended its collaboration with Peking University with a fifth strategic drug discovery agreement, demonstrating long-term commitment to external partnerships. Through these initiatives—combining AI technology with established research partnerships—Bayer exemplifies how major pharmaceutical companies are modernizing their discovery processes to remain competitive in an increasingly AI-driven pharmaceutical landscape.